Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
busulfan + melphalan + thiotepa
- Development stage
- Unknown
- Modality
- Nucleic Acid-Directed Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Intravenous
01
Overview
Busulfan + melphalan + thiotepa is a combination chemotherapy regimen consisting of three alkylating agents—busulfan, melphalan, and thiotepa. This regimen is primarily used as a high-dose conditioning treatment before autologous or allogeneic stem cell transplantation in patients with aggressive hematologic malignancies such as non-Hodgkin's lymphoma, Hodgkin's disease, acute leukemias, and central nervous system lymphomas. The combination works by cross-linking DNA strands and inhibiting DNA replication and transcription, leading to cell death in rapidly dividing cancer cells. It is often chosen for patients who have previously received radiotherapy that precludes the use of total body irradiation-based regimens[2][3][4][6].
- Other names
- TBM regimenthiotepa + busulfan + melphalan
02
Targets
DNA
Beyond the preview
Go deeper on busulfan + melphalan + thiotepa.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on busulfan + melphalan + thiotepa.